Despite its homology to angiostatin Apolipoprotein(a) does not affect angiogenesis

Experimental and Molecular Pathology

Volumn 65, Issue 2, 1998, Pages 53-63

  Lou, Xing Jian ^a   Kwan, Helen H ^b   Prionas, Stavros D ^b   Yang, Zhuoying J ^a   Lawn, Richard M ^a   Fajardo, Luis F ^b,c  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c VA PALO ALTO HEALTH CARE SYSTEM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOSTATIN; APOLIPOPROTEIN A; BASIC FIBROBLAST GROWTH FACTOR;

ANGIOGENESIS; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CELL PROLIFERATION; CONTROLLED STUDY; FEMALE; GROWTH REGULATION; MICROVASCULATURE; MOUSE; NONHUMAN; SIGNAL TRANSDUCTION;

ANIMALIA; MUS MUSCULUS;

EID: 0007623386     PISSN: 00144800     EISSN: None     Source Type: Journal    
DOI: 10.1006/exmp.1998.2230     Document Type: Article

References (39)

1. Assmann, G., Schulte, H., and ven Eckardstein, A. (1996). Hypertriglyceridemia and elevated lipoprotein(a) are risk factors for major coronary events in middle-aged men. Am. J. Cardiol. 77, 1179-1184.
2. Bostom, A. G., Cupples, L. A., Jenner, J. L., Ordovas, J. M., Seman, L. L., Wilson, P. W. F., Schaefer, E. J., and Castelli, W. P. (1996). Elevated plasma lipoprotein(a) and premature coronary heart disease in Framingham men: A prospective study. JAMA 276, 544-548.
3. Cao, Y, Ji, R. W., Davidson, D., Schaller, J., Marti, D., Sohndel, S., McCance, S. G., O'Reilly, M. S., Llinas, M., and Folkman, J. (1996). Kringle domains of human angiostatin. Characterization of the anti-proliferative activity on endothelial cells. J. Biol. Chem. 271, 29461-29467.
4. Care, A., Silvani, A., Meccia, E., Mattia, G., Stoppacciaro, A., Parmiani, G., Peschle, C., and Colombo, M. P. (1996). HOXB7 constitutively activates basic fibroblast growth factor in melanomas. Mol. Cell. Biol. 16, 4842-4851.
5. Chiesa, G., Hobbs, H. H., Koschinsky, M. L., Lawn, R. M., Maika, S. D., and Hammer, R. E. (1992). Reconstitution of lipoprotein (a) by infusion of human low density lipoprotein into transgenic mice expressing human apolipoprotein(a). J. Biol. Chem. 267, 24369-24374.
6. Dameron, K. M., Volpert, O. V., Tainsky, M. A., and Bouck, N. (1994). Control of angiogenesis in fibroblasts by p53 regulation of thrombospondin-1. Science 265, 1582-1584.
7. Fajardo, L. F., Kowalski, J., Kwan, H. H., Prionas, S. D., and Allison, A. C. (1988). The disc angiogenesis system. Lab. Invest. 58, 718-724.
8. Fajardo, L. F., Kwan, H. H., Kowalski, J., Prionas, S. D., and Allison, A. C. (1992). Dual role of tumor necrosis factor-a in angiogenesis. Am. J. Pathol. 140, 539-544.
9. Folkman, J. (1995a). Angiogenesis in cancer, vascular, rheumatoid and other disease. Nature Med. 1, 27-31.
10. Folkman, J. (1995b). Seminars in Medicine of the Beth Israel Hospital, Boston. Clinical applications of research on angiogenesis. N. Engl. J. Med. 333, 1757-1763.
11. Furie, B., and Furie, B. C. (1988). The molecular basis of blood coagulation. Cell 53, 505-518.
12. Grant, D. S., Kleinman, H. K., Goldberg, I. D., Bhargava, M. M., Nickoloff, B. J., Kinsella, J. L., Polverini, P., and Rosen, E. M. (1993). Scatter factor induces blood vessel formation in vivo. Proc. Natl. Acad. Sci. USA 90, 1937-1941.
13. Gunzler, W. A., Steffens, G. J., Otting, F., Kim, S. M., Frankus, E., and Flohe, L. (1982). The primary structure of high molecular mass urokinase from human urine. The complete amino acid sequence of the A chain. Hoppe Seylers Z. Physiol. Chem. 363, 1155-1165.
14. Iwasaka, C., Tanaka, K., Abe, M., and Sato, Y. (1996). Ets-1 regulates angiogenesis by inducing the expression of urokinase-type plasminogen activator and matrix metalloproteinase-1 and the migration of vascular endothelial cells. J. Cell. Physiol. 169, 522-531.
15. Koschinsky, M. L., Tomlinson, J. E., Zioncheck, T. F., Schwartz, K., Eaton, D. L., and Lawn, R. M. (1991). Apolipoprotein(a): Expression and characterization of a recombinant form, of the protein in mammalian cells. Biochemistry 30, 5044-5051.
16. Kostner, K. M., Maurer, G., Huber, K., Stefenelli, T., Dieplinger, H., Steyrer, E., and Kostner, G. M. (1996). Urinary excretion of apo(a) fragments. Arteriosclerosis Thromb. Vasc. Biol. 16, 905-911.
17. Kowalski, J., Kwan, H. H., Prionas, S. D., Allison, A. C., and Fajardo, L. F. (1992). Characterization and applications of the disc angiogenesis system. Exp. Mol. Pathol. 56, 1-19.
18. Lawn, R. M., Pearle, A. D., Kunz, L. L., Rubin, E. M., Reckless, J., Metcalfe, J. C., and Grainger, D. J. (1996). Feedback mechanism of focal vascular lesion formation in transgenic apolipoprotein(a) mice. J. Biol. Chem. 271, 31367-31371.
19. Lawn, R. M., Wade, D. P., Hammer, R. E., Chiesa, G., Verstuyft, J. G., and Rubin, E. M. (1992). Atherogenesis in transgenic mice expressing human apoliprotein(a). Nature 360, 670-672.
20. Masiakowski, P., and Carroll, R. D. (1992). A novel family of cell surface receptors with tyrosine kinase-like domain. J. Biol. Chem. 267, 26181-26190.
21. McLean, J. W., Tomlinson, J. E., Kuang, W. J., Eaton, D. L., Chen, E. Y., Fless, G. M., Scanu, A. M., and Lawn, R. M. (1987). cDNA sequence of human apolipoprotein(a) is homologous to plasminogen. Nature 330, 132-137.
22. Mooser, V., Seabra, M. C., Abedin, M., Landschulz, K. T., Marcovina, S., and Hobbs, H. H. (1996). Apolipoprotein(a) kringle 4-containing fragments in human urine. Relationship to plasma levels of lipoprotein(a). J. Clin. Invest. 97, 858-864.
23. Nakamura, T., Nishizawa, T., Hagiya, M., Seki, T., Shimonishi, M., Sugimura, A., Tashiro, K., and Shimuzu, S. (1989). Molecular cloning and expression of human hepatocyte growth factor. Nature 342, 440-443.
24. O'Brien, T., Cranston, D., Fuggle, S., Bicknell, R., and Harris, A. L. (1997). Two mechanisms of basic fibroblast growth factor-induced angiogenesis in bladder cancer. Cancer Res. 57, 136-140.
25. O'Reilly, M. S., Boehm, T., Shing, Y., Fukai, N., Vasios, G., Lane, W. S., Flynn, E., Birkhead, J. R., Olsen, B. R., and Folkman, J. (1997). Endostatin: An endogenous inhibitor of angiogenesis and tumor growth. Cell 88, 277-285.
26. O'Reilly, M. S., Holmgren, L., Chen, C., and FOlkman, J. (1996). Angiostatin induces and sustains dormancy of human primary tumors in mice. Nature Med. 2, 689-692.
27. O'Reilly, M. S., Holmgren, L., Shing, Y., Chen, C., Rosenthal, R. A., Moses, M., Lane, W. S., Cao, Y., Sage, E. H., and Folkman, J. (1994). Angiostatin: A novel angiogenesis inhibitor that mediates the suppression of metastases by a Lewis lung carcinoma. Cell 79, 315-328.
28. Oishi, I., Sugiyama, S., Liu, Z. J., Yamamura, H., Nishida, Y., and Minami, Y (1997). A novel Drosophila receptor tyrosine kinase expressed specifically in the nervous system. Unique structural features and implication in developmental signaling. J. Biol. Chem. 272, 11916-11923.
29. Palabrica, T. M., Liu, A. C., Aronovitz, M. J., Furie, B., Lawn, R. M., and Furie, B. C. (1995). Antifibrinolytic activity of apolipoprotein(a) in vivo: Human apolipoprotein(a) transgenic mice are resistant to thrombolysis. Nature Med. 1, 256-259.
30. Pennica, D., Holmes, W. E., Kohr, W. J., Harkins, R. N., Vehar, G. A., Ward, C. A., Bennett, W. F., Yelverton, E., Seeburg, P. H., Heyneker, H. L., Goeddel, D. V., and Collen, D. (1983). Cloning and expression of human tissue-type plasminogen activator cDNA in E. coli. Nature 301, 214-221.
31. Samaniego, F., Markham, P. D., Gendelman, R., Gallo, R. C., and Ensoli, B. (1997). Inflammatory cytokines induce endothelial cells to produce and release basic fibroblast growth factor and to promote Kaposi's sarcoma-like lesions in nude mice. J. Immunol. 158, 1887-1894.
32. Scanu, A. M., and Fless, G. M. (1990). Lipoprotein(a): Heterogeneity and biological relevance. J. Clin. Invest. 85, 1709-1715.
33. Thery, C., and Stern, C. D. (1996). Roles of kringle domain-containing serine proteases in epithelial-mesenchymal transitions during embryonic development. Acta. Anat. 156, 162-172.
34. Tkachuk, V., Stepanova, V., Little, P. J., and Bobik, A. (1996). Regulation and role of urokinase plasminogen activator in vascular remodelling. Clin. Exp. Pharmacol. Physiol. 23, 759-765.
35. Utermann, G. (1989). The mysteries of lipoprotein(a). Science 246, 904-910.
36. van Hinsbergh, V. W., Koolwijk, P., and Hanemaaijer, R. (1997). Role of fibrin and plasminogen activators in repair-associated angiogenesis. In vitro studies with human endothelial cells. EXS 79, 391-411.
37. Weidner, K. M., Sachs, M., and Birchmeier, W. (1993). The Met receptor tyrosine kinase transduces motility, proliferation, and morphogenic signals of scatter factor/hepatocyte growth factor in epithelial cells. J. Cell. Biol. 121, 145-154.
38. Welling, T. H., Huber, T. S., Messina, L. M., and Stanley, J. C. (1996). Tissue plasminogen activator increases canine endothelial cell proliferation rate through a plasmin-independent, receptor-mediated mechanism. J. Surg. Res. 66, 36-42.
39. Yebra, M., Parry, G. C. N., Stromblad, S., Mackman, N., Rosenberg, S., Mueller, B. M., and Cheresh, D. A. (1996). Requirement of receptor-bound urokinase-type plasminogen activator for integrin alphavbeta5-directed cell migration. J. Biol. Chem. 271, 29393-29399.